Posted by Michael Wonder on 02 Nov 2016
TGA publishes AusPAR for Esmya
2 November 2016 - The TGA has published an AusPAR for Vifor Pharma's Esmya.
The TGA approved Esmya (ulipristal acetate) on 11 May 2016 for intermittent treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.
